ResearcherTongji HospitalNo recent work listed

Guangyuan Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8060-4917; OpenAlex author ID A5062837781. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro. Last author DOI 10.7150/jca.21306 ↗
Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2. Co-author DOI 10.1177/1010428317698364 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lin Yang · 1 shared paper, 2018 · strength 0.09
- Paper Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro. DOI 10.7150/jca.21306 ↗
Guopeng Zhang · 1 shared paper, 2017 · strength 0.07
- Paper Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of K… DOI 10.1177/1010428317698364 ↗
Shunfang Liu · 1 shared paper, 2017 · strength 0.07
- Paper Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of K… DOI 10.1177/1010428317698364 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.